test44
https://www.cytel.com/blog/use-of-bayesian-analysis-in-platform-trials-webinar-by-dr-kyle-wathen
May 21, 2021
Most of us are familiar with the concept of platform clinical trials as they have gained popularity in the recent..
Read article
test44
https://www.cytel.com/blog/single-arm-multi-stage-phase-2-cancer-trials-reviewing-essential-new-designs
March 5, 2021
Early stage Phase 2 clinical trials are often designed as multi-stage single arm trials, which quickly identify..
Read article
test44
https://www.cytel.com/blog/selecting-your-next-clinical-trial-design-using-quantitative-decision-methods
February 19, 2021
C-Suite and R&D Decision-Makers are always striving to make evidence-driven decisions. Yet the rules by which evidence..
Read article
test44
https://www.cytel.com/blog/eu_eugm_2018_stephensenn
October 5, 2018
We are delighted that Stephen Senn will be joining us at the EUGM on November 14th and 15th in Darmstadt, Germany. In..
Read article
test44
https://www.cytel.com/blog/eu_eugm_2018_heikogotte
September 27, 2018
In this blog, we talk with Heiko Götte, Senior Expert Biostatistician at Merck about his upcoming presentation at..
Read article
test44
https://www.cytel.com/blog/webinar-replay-go-no-go-decision-making
October 31, 2017
As part of Cytel's new Trial Innovations Webinar Series, Pat Mitchell, Statistical Science Director at AstraZeneca..
Read article
test44
https://www.cytel.com/blog/improving-go-no-go-decision-making-custom-software
March 24, 2017
Robust go/no-go (GNG) decision-making is essential for effectively managing risk across a clinical portfolio. In early..
Read article
test44
https://www.cytel.com/blog/cmo-biostatistician-connection
June 7, 2016
At the recent CMO Summit East James ( Jim) Bolognese, Cytel’s Senior Director of Strategic Consulting, and Lou..
Read article
test44
https://www.cytel.com/blog/cost-of-pharma-development
April 5, 2016
Cost of pharmaceutical development and R&D productivity is an ongoing industry concern, consistently discussed in..
Read article